Alpha Tau Medical Ltd. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for DRTS, updated each market day.
DRTS AI Sentiment
AI sees no strong directional signal for Alpha Tau Medical Ltd. Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Alpha Tau Medical Ltd. Ordinary Shares
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Exchange
Market Cap
$646,871,566
Cap Tier
Employees
121
Listed Since
March 8, 2022
Website
DRTS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DRTS Volatility
Alpha Tau Medical Ltd. Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
